What do you think about the fact that this stock is only at 2 bucks and was just the other at 1.50 given the impending fda descision. from what i understand this drug could have a lot of sales its first year if approved. stocks like dndn rose fast on data release..why do you think appas share price is so low?
Market Data 
Markets 
AI
